Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Breast (Edinburgh, Scotland)|June 27, 2017
Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breastMassimiliano Gennaro, Maria Carmen De Santis, Luigi Mariani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trialMila Donker, Saskia Litière, Gustavo Werutsky, et al.
BMC Cancer|May 25, 2018
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancerLuca Forte, Federica Turdo, Cristina Ghirelli, et al.
International Journal of Cancer|January 30, 2024
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressivenessIlona Rybinska, Nunzia Mangano, Sandra L Romero-Cordoba, et al.
Oncogene|December 24, 2003
Immunological and pathobiological roles of fibulin-1 in breast cancerSerenella M Pupa, William S Argraves, Stefania Forti, et al.
Tumori|May 9, 2015
A breast cancer clinical registry in an Italian comprehensive cancer center: an instrument for descriptive, clinical, and experimental researchPaolo Baili, Michele Torresani, Roberto Agresti, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2015
Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 studyMilena Sant, Maria Dolores Chirlaque Lopez, Roberto Agresti, et al.
Radiation Oncology (London, England)|March 24, 2018
Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancerLaura Lozza, Laura Fariselli, Marco Sandri, et al.
Oncotarget|September 15, 2016
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancersFederica Turdo, Francesca Bianchi, Patrizia Gasparini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot studyFlavio Crippa, Roberto Agresti, Marco Sandri, et al.
Pageof 5